Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

The treatment is safe and shows promise for metastatic breast cancer.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Finasteride may cause pseudoporphyria, a blistering skin condition.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Modified phenol peels effectively reduced stubborn skin pigmentation in patients with Lichen Planus Pigmentosus.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

A new method to make Finasteride is more cost-effective and yields 16%.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Adding more zinc oxide nanoparticles increases sunblock SPF.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Niosomes are a promising and effective way to deliver drugs through the skin.

Antizyme slows skin tumor growth by reducing cell growth in mice.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Photodynamic therapy can potentially remove nonpigmented hair by damaging hair follicles.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Nilotinib can cause keratosis pilaris, a skin condition.